Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
01 2Rusan Pharma
02 1AOP Orphan
03 4Accord healthcare
04 1Acino Pharma (Pty) Ltd
05 6Actavis Inc
06 1Advanz Pharma
07 1Apotex Inc
08 1Barr Laboratories
09 1Bausch Health
10 1Chartwell Pharmaceuticals llc
11 1Currax
12 1Elite Laboratories
13 1Esjay Pharma
14 4Mallinckrodt Pharmaceuticals
15 1Molteni Farmaceutici
16 1OrPha Swiss
17 1Orexigen Therapeutics Ireland Limited (1)
18 2POA Pharma Scandinavia AB
19 6Pfizer Inc
20 1Pluviaendo
21 1SIRTON MEDICARE Srl
22 1Sterinova Inc.
23 1Sun Pharmaceutical Industries Limited
24 2Teva Pharmaceutical Industries
25 2Zambon Switzerland
26 2Blank
01 1Antic-calc Tablet, Film Coated
02 12CAPSULE, EXTENDED RELEASE;ORAL
03 1Capsule
04 1Coated Tablet
05 1Depot tablet
06 4FILM COATED PILL
07 1Film Coated Tablet
08 1Filmtabl
09 2Naltrexone 50Mg 10 Units Oral Use
10 3Naltrexone 50Mg 14 Joined' Oral Use
11 1TAB
12 3TABLET
13 1TABLET (EXTENDED-RELEASE)
14 1TABLET, EXTENDED RELEASE;ORAL
15 10TABLET;ORAL
16 1Tab
17 2Tablet
18 1Tablet Implant
01 14DISCN
02 1Generic
03 1Originator
04 9RX
05 22Blank
01 128 Accord Naltrexone 50Mg Film-Coated Tablets Efg
02 1APO-NALTREXONE
03 2Antaxone
04 2CONTRAVE
05 1Contrave
06 6EMBEDA
07 1Mysimba
08 9NALTREXONE HYDROCHLORIDE
09 1NALTREXONE HYDROCHLORIDE TABLETS USP
10 1Nalorex
11 1Naltima
12 1Naltrexin
13 1Naltrexone
14 1Naltrexone Abcur
15 1Naltrexone Accord
16 2Naltrexone POA Pharma
17 1Narcoral
18 1Opizone
19 2REVIA
20 1Revia 50Mg 28 Coated Tablets
21 6TROXYCA ER
22 4Blank
01 4Canada
02 2India
03 5Italy
04 2Norway
05 2South Africa
06 2Spain
07 4Sweden
08 1Switzerland
09 1Turkey
10 1U.S.A
11 23USA
Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging : Pack Size 3x10; 2x14; 10x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet Implant
Dosage Strength : 765mg
Packaging : Pack Size 2 Tablets in 1 Carton; 1 Tablets in 1 Carton
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2011-08-17
Application Number : 91205
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-05-08
Application Number : 74918
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
Brand Name : CONTRAVE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 90MG;8MG
Packaging :
Approval Date : 2014-09-10
Application Number : 200063
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1999-05-26
Application Number : 75274
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2000-03-08
Application Number : 75434
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2002-03-22
Application Number : 76264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2002-03-22
Application Number : 76264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2002-03-22
Application Number : 76264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
Brand Name : TROXYCA ER
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 1.2MG;10MG
Packaging :
Approval Date : 2016-08-19
Application Number : 207621
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
Brand Name : TROXYCA ER
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 2.4MG;20MG
Packaging :
Approval Date : 2016-08-19
Application Number : 207621
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2012-02-24
Application Number : 90356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REVIA
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1984-11-20
Application Number : 18932
Regulatory Info : DISCN
Registration Country : USA
